Renustat™ 50 mg Tablet is a medication developed by Square Pharmaceuticals Ltd. in Bangladesh. It contains Roxadustat, a first-in-class oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor. Roxadustat stimulates erythropoiesis (red blood cell production) by increasing endogenous erythropoietin levels and improving iron regulation, making it effective in treating anemia associated with chronic kidney disease (CKD).